XPO XPO notches 134 percent Q4 2025 EPS beat even as shares dip slightly in todays trading Is Inhibikase Therapeutics IKT stock reversing trend Inhibikase Therapeutics notches 136 EPS beat on narrower loss GSBD Goldman Q4 2025 EPS beats consensus estimates shares rise 032 percent after earnings release Xenon Pharmaceuticals XENE Unveils Robust Azetukalner Phase III Data Q3 NDA Filing Plans at Bloom Burton Conference Semtech Corporation SMTC Trend Analysis Q1 2026 Profit Disappoints FSI Flexible shares fall 414 after Q4 2025 EPS lands far below analyst consensus estimates Coinbase Global Inc COIN Launches Bespoke Blockchain Wealth Program for HighNetWorth Investors BNS Scotiabank notches 39 percent Q1 2026 EPS beat yet shares dip 138 percent amid muted investor reaction